DalCor Pharmaceuticals

DalCor Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Montreal, Quebec, with offices in Zug, Switzerland, Leatherhead in the United Kingdom, and Sarasota, Florida. It is developing dalcetrapib, positioned as the first pharmacogenetic precision medicine in cardiovascular disease, targeted specifically at patients carrying the AA genotype at the rs1967309 variant of the ADCY9 gene — a genotype present in up to 20% of the general population and in more than 40% of populations of African ancestry. DalCor holds the worldwide exclusive license to develop, manufacture and commercialise dalcetrapib together with rights to the companion genetic marker. The compound is being evaluated in Dal-GenE-2 (DAL-302), a Phase 3 double-blind randomized placebo-controlled cardiovascular outcomes confirmatory trial in 2,000 post-acute-coronary-syndrome patients with the ADCY9 AA genotype, coordinated by the Montreal Health Innovations Coordinating Centre and following the dal-GenE (DAL-301) trial, which showed a 21% relative risk reduction in fatal and non-fatal myocardial infarction across 6,149 patients in 34 countries. DalCor runs no developer program and publishes no product API; the only machine-readable surface it exposes is the anonymously readable WordPress REST content API behind dalcorpharma.com, which serves the bilingual English/French corporate site.

DalCor Pharmaceuticals publishes 7 APIs on the APIs.io network, including Categories API, Comments API, Discovery API, and 4 more. Tagged areas include Company, pharmaceuticals, biotechnology, cardiovascular, and precision-medicine.

DalCor Pharmaceuticals’ developer surface includes support, authentication, and 23 more developer resources.

🌐 Visit website 📡 Source on GitHub

29.2/100 thin ▬ flat Agent 33/100 agent aware Full breakdown ↓
scored 2026-08-12 · rubric v0.11.0

7 APIs

Companypharmaceuticalsbiotechnologycardiovascularprecision-medicinepharmacogenomicsclinical-trialslife-sciencescontent-api

Kin Score

Kin Score How this is scored →
scored 2026-08-12 · rubric v0.11.0

Composite quality — 29.2/100 · thin

Contract Quality 12.6 / 21

Developer Ergonomics 2.9 / 17

Commercial Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Governance 1.2 / 10

Discoverability 6.9 / 9

Regulatory Posture 3.9 / 15

Agent readiness — 33/100 · agent aware

Machine-Readable Contract 18 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 10 / 10

Idempotency 0 / 9

Stable Error Semantics 8 / 8

Request/Response Examples 7 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 5 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/dalcor-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

APIs 7

Individual APIs this provider publishes, each with its own machine-readable definition.

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

WellKnown

WellKnown

LLMsTxt

LLMsTxt

AgentSkill

AgentSkill

Design & Contract 5

Pagination, idempotency, versioning, errors, and events

Conventions

Conformance

ErrorCatalog

Lifecycle

DataModel

Access & Security 2

Authentication, authorization, and security posture

Authentication

Authentication

DomainSecurity

DomainSecurity

Operate 3

Status, limits, changes, and where to get help

PressReleases

PressReleases

Contact

Contact

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

About

Partners

BlogRSS

LinkedIn

Other 6

Properties that don't map to a standard resource type

Overlay

Management

BoardOfDirectors

Science

Publications

SecondaryMarket

Source (apis.yml)

aid: dalcor-pharmaceuticals
name: DalCor Pharmaceuticals
description: DalCor Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Montreal,
  Quebec, with offices in Zug, Switzerland, Leatherhead in the United Kingdom, and Sarasota, Florida. It is developing dalcetrapib,
  positioned as the first pharmacogenetic precision medicine in cardiovascular disease, targeted specifically at patients
  carrying the AA genotype at the rs1967309 variant of the ADCY9 gene — a genotype present in up to 20% of the general population
  and in more than 40% of populations of African ancestry. DalCor holds the worldwide exclusive license to develop, manufacture
  and commercialise dalcetrapib together with rights to the companion genetic marker. The compound is being evaluated in Dal-GenE-2
  (DAL-302), a Phase 3 double-blind randomized placebo-controlled cardiovascular outcomes confirmatory trial in 2,000 post-acute-coronary-syndrome
  patients with the ADCY9 AA genotype, coordinated by the Montreal Health Innovations Coordinating Centre and following the
  dal-GenE (DAL-301) trial, which showed a 21% relative risk reduction in fatal and non-fatal myocardial infarction across
  6,149 patients in 34 countries. DalCor runs no developer program and publishes no product API; the only machine-readable
  surface it exposes is the anonymously readable WordPress REST content API behind dalcorpharma.com, which serves the bilingual
  English/French corporate site.
image: https://dalcorpharma.com/kicmeefo/2023/09/dalcor-logo.png
url: https://raw.githubusercontent.com/api-evangelist/dalcor-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- pharmaceuticals
- biotechnology
- cardiovascular
- precision-medicine
- pharmacogenomics
- clinical-trials
- life-sciences
- content-api
apis:
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-categories-api
  name: DalCor Pharmaceuticals Categories API
  description: Post categories
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Categories
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-categories-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-comments-api
  name: DalCor Pharmaceuticals Comments API
  description: Comments on posts (collection is empty on this site)
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Comments
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-comments-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-discovery-api
  name: DalCor Pharmaceuticals Discovery API
  description: Site index, namespace route index, content types, taxonomies and statuses
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Discovery
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-discovery-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-media-api
  name: DalCor Pharmaceuticals Media API
  description: Media library items (logos, poster PDFs/JPEGs, trial imagery)
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Media
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-media-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-pages-api
  name: DalCor Pharmaceuticals Pages API
  description: Corporate, science and clinical-trial pages
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Pages
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-pages-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-posts-api
  name: DalCor Pharmaceuticals Posts API
  description: DalCor press releases and corporate news
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Posts
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-posts-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
- aid: dalcor-pharmaceuticals:dalcor-pharmaceuticals-search-api
  name: DalCor Pharmaceuticals Search API
  description: Cross-content search
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://dalcorpharma.com/wp-json
  tags:
  - Search
  properties:
  - type: OpenAPI
    url: openapi/dalcor-pharmaceuticals-search-api-openapi.yml
  - type: Authentication
    url: authentication/dalcor-pharmaceuticals-authentication.yml
  - type: ErrorCatalog
    url: errors/dalcor-pharmaceuticals-problem-types.yml
  - type: Conventions
    url: conventions/dalcor-pharmaceuticals-conventions.yml
  - type: DataModel
    url: data-model/dalcor-pharmaceuticals-data-model.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/dalcor-pharmaceuticals-content-overlay.yaml
- type: Website
  url: https://dalcorpharma.com/
- type: About
  url: https://dalcorpharma.com/about/
- type: Management
  url: https://dalcorpharma.com/about/management/
- type: BoardOfDirectors
  url: https://dalcorpharma.com/about/board-of-directors/
- type: Partners
  url: https://dalcorpharma.com/about/partners/
- type: Science
  url: https://dalcorpharma.com/science/cardiovascular-diseases/
- type: Publications
  url: https://dalcorpharma.com/science/publications/
- type: PressReleases
  url: https://dalcorpharma.com/press-releases/
- type: BlogRSS
  url: https://dalcorpharma.com/feed/
- type: Contact
  url: https://dalcorpharma.com/contact-us/
- type: Support
  url: https://dalcorpharma.com/contact-us/
- type: PrivacyPolicy
  url: https://dalcorpharma.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/dalcor-pharmaceuticals/
- type: SecondaryMarket
  url: https://forgeglobal.com/dalcor-pharmaceuticals_stock/
- type: Authentication
  url: authentication/dalcor-pharmaceuticals-authentication.yml
- type: Conventions
  url: conventions/dalcor-pharmaceuticals-conventions.yml
- type: Conformance
  url: conformance/dalcor-pharmaceuticals-conformance.yml
- type: ErrorCatalog
  url: errors/dalcor-pharmaceuticals-problem-types.yml
- type: Lifecycle
  url: lifecycle/dalcor-pharmaceuticals-lifecycle.yml
- type: DataModel
  url: data-model/dalcor-pharmaceuticals-data-model.yml
- type: WellKnown
  url: well-known/dalcor-pharmaceuticals-well-known.yml
- type: DomainSecurity
  url: security/dalcor-pharmaceuticals-domain-security.yml
- type: LLMsTxt
  url: llms/dalcor-pharmaceuticals-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-04'
  status: enriched
  artifacts_added: 15
  pass: local-v1

DalCor Pharmaceuticals

Kin Score

APIs 7

DalCor Pharmaceuticals Categories API

DalCor Pharmaceuticals Comments API

DalCor Pharmaceuticals Discovery API

DalCor Pharmaceuticals Media API

DalCor Pharmaceuticals Pages API

DalCor Pharmaceuticals Posts API

DalCor Pharmaceuticals Search API

Security Posture 2

Dalcor Pharmaceuticals Authentication

Dalcor Pharmaceuticals Domain Security

Resources